Andrew M Courtwright1,2, Ellen M Robinson1,3, Katelyn Feins4, Jennifer Carr-Loveland4, Vivian Donahue5,6, Nathalie Roy7, Jessica McCannon8. 1. 1 Institute for Patient Care, Patient Care Services. 2. 2 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 3. 3 Yvonne L. Munn Center for Nursing Research, Patient Care Services. 4. 4 Cardiothoracic Surgical Intensive Care Unit. 5. 5 Cardiac Surgical Intensive Care Unit. 6. 6 Cardiac Intensive Care Unit. 7. 7 Division of Cardiac Surgery, and. 8. 8 Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts; and.
Abstract
RATIONALE: The clinical ethics literature on extracorporeal membrane oxygenation (ECMO) has been focused primarily on identifying hypothetical ethical dilemmas that may arise with the use of this technology. Little has been written on the actual experience with ECMO-related ethical questions. OBJECTIVES: To describe the role of an ethics consultation service during the expansion of a single-center ECMO program in a cardiothoracic surgery intensive care unit (CSICU) and to identify common ethical themes surrounding the use of ECMO. METHODS: We conducted a retrospective, descriptive cohort study of all ECMO ethics consultation cases in the CSICU at a large academic hospital between 2013 and 2015. MEASUREMENTS AND MAIN RESULTS: During the study period, 113 patients were placed on ECMO in the CSICU, 45 (39.5%) of whom were seen by the ethics committee. In 2013, 10 of 46 (21.7%) patients received ethics consults. By 2015, 28 of 30 (93.3%) of patients were seen by ethics consultants. Initial consultation occurred at a median of 2 days (interquartile range, 1-6 d) following initiation of ECMO. The most common ethical issue involved disagreement about the ongoing use of ECMO, which included multiple axes: Disagreement among health care providers, disagreement among surrogates, and disagreement between health care providers and surrogates over stopping or continuing ECMO. CONCLUSIONS: In our experience with integrating ethics consultation into the routine care of ECMO patients, most of the ethical questions more closely resembled traditional concerns about the appropriate use of any life-sustaining treatment rather than the novel dilemmas imagined in the current literature.
RATIONALE: The clinical ethics literature on extracorporeal membrane oxygenation (ECMO) has been focused primarily on identifying hypothetical ethical dilemmas that may arise with the use of this technology. Little has been written on the actual experience with ECMO-related ethical questions. OBJECTIVES: To describe the role of an ethics consultation service during the expansion of a single-center ECMO program in a cardiothoracic surgery intensive care unit (CSICU) and to identify common ethical themes surrounding the use of ECMO. METHODS: We conducted a retrospective, descriptive cohort study of all ECMO ethics consultation cases in the CSICU at a large academic hospital between 2013 and 2015. MEASUREMENTS AND MAIN RESULTS: During the study period, 113 patients were placed on ECMO in the CSICU, 45 (39.5%) of whom were seen by the ethics committee. In 2013, 10 of 46 (21.7%) patients received ethics consults. By 2015, 28 of 30 (93.3%) of patients were seen by ethics consultants. Initial consultation occurred at a median of 2 days (interquartile range, 1-6 d) following initiation of ECMO. The most common ethical issue involved disagreement about the ongoing use of ECMO, which included multiple axes: Disagreement among health care providers, disagreement among surrogates, and disagreement between health care providers and surrogates over stopping or continuing ECMO. CONCLUSIONS: In our experience with integrating ethics consultation into the routine care of ECMO patients, most of the ethical questions more closely resembled traditional concerns about the appropriate use of any life-sustaining treatment rather than the novel dilemmas imagined in the current literature.
Entities:
Keywords:
ethics; extracorporeal membrane oxygenation; life-sustaining treatment; mechanical circulatory support
Authors: L Gattinoni; A Pesenti; D Mascheroni; R Marcolin; R Fumagalli; F Rossi; G Iapichino; G Romagnoli; L Uziel; A Agostoni Journal: JAMA Date: 1986-08-15 Impact factor: 56.272
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: N Zamperetti; C Ronco; A Brendolan; R Bellomo; G Canato; M Irone; S Barbacini; R Carraro; G La Greca; P Piccinni; M Dan Journal: Intensive Care Med Date: 2000-04 Impact factor: 17.440
Authors: Gina M Piscitello; Rene S Bermea; John W Stokes; Whitney D Gannon; Anthony J Kanelidis; Megan Konopka; Claire Shappell; Laura K Frye; Patrick G Lyons; Mark Siegler; William F Parker Journal: Am J Hosp Palliat Care Date: 2021-08-20 Impact factor: 2.090
Authors: Andrew M Courtwright; Kim S Erler; Julia I Bandini; Mary Zwirner; M Cornelia Cremens; Thomas H McCoy; Ellen M Robinson; Emily Rubin Journal: J Bioeth Inq Date: 2021-02-26 Impact factor: 2.216
Authors: Bernadine Dao; Julian Savulescu; Jacky Y Suen; John F Fraser; Dominic J C Wilkinson Journal: BMC Med Ethics Date: 2021-06-01 Impact factor: 2.652
Authors: Daniel Drewniak; Giovanna Brandi; Philipp Karl Buehler; Peter Steiger; Niels Hagenbuch; Sabine Stamm-Balderjahn; Liane Schenk; Ana Rosca; Tanja Krones Journal: Med Decis Making Date: 2021-10-23 Impact factor: 2.583